Literature DB >> 18496712

Clara cell secretory protein and bronchopulmonary dysplasia in prematurely born infants.

Anne Greenough.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18496712     DOI： 10.1007/s00431-008-0746-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  14 in total

1.  Altered pulmonary response to hyperoxia in Clara cell secretory protein deficient mice.

Authors:  C J Johnston; G W Mango; J N Finkelstein; B R Stripp
Journal:  Am J Respir Cell Mol Biol       Date:  1997-08       Impact factor: 6.914

2.  Time and pressure dependence of transvascular Clara cell protein, albumin, and IgG transport during ventilator-induced lung injury in mice.

Authors:  Sawako Yoshikawa; Judy A King; Susan D Reynolds; Barry R Stripp; James C Parker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-03       Impact factor: 5.464

3.  CC10 administration to premature infants: in search of the "silver bullet" to prevent lung inflammation.

Authors:  Stephen E Welty
Journal:  Pediatr Res       Date:  2005-05-05       Impact factor: 3.756

4.  Clara cell secretory protein (CC16) as a peripheral blood biomarker of lung injury in ventilated preterm neonates.

Authors:  Kosmas Sarafidis; Theodora Stathopoulou; Elisavet Diamanti; Vasiliki Soubasi; Charalambos Agakidis; Aikaterini Balaska; Vasiliki Drossou
Journal:  Eur J Pediatr       Date:  2008-06-03       Impact factor: 3.183

5.  The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome.

Authors:  Carolyn R Levine; Ira H Gewolb; Kristen Allen; Richard W Welch; James M Melby; Simcha Pollack; Thomas Shaffer; Aprile L Pilon; Jonathan M Davis
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

6.  Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability.

Authors:  C Hermans; B Knoops; M Wiedig; K Arsalane; G Toubeau; P Falmagne; A Bernard
Journal:  Eur Respir J       Date:  1999-05       Impact factor: 16.671

Review 7.  Ventilator-induced lung injury: lessons from experimental studies.

Authors:  D Dreyfuss; G Saumon
Journal:  Am J Respir Crit Care Med       Date:  1998-01       Impact factor: 30.528

8.  Clara cell secretory protein modulates lung inflammatory and immune responses to respiratory syncytial virus infection.

Authors:  Shan-Ze Wang; Cynthia L Rosenberger; Yi-Xiao Bao; James M Stark; Kevin S Harrod
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

9.  Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury.

Authors:  P G Jorens; Y Sibille; N J Goulding; F J van Overveld; A G Herman; L Bossaert; W A De Backer; R Lauwerys; R J Flower; A Bernard
Journal:  Eur Respir J       Date:  1995-10       Impact factor: 16.671

10.  Safety and efficacy of intratracheal recombinant human Clara cell protein in a newborn piglet model of acute lung injury.

Authors:  Sudhish Chandra; Jonathan M Davis; Steven Drexler; Jolanta Kowalewska; Darrin Chester; Hshi-Chi Koo; Simcha Pollack; Richard Welch; Aprile Pilon; Carolyn R Levine
Journal:  Pediatr Res       Date:  2003-06-18       Impact factor: 3.756
View more
  2 in total

Review 1.  An update on pharmacologic approaches to bronchopulmonary dysplasia.

Authors:  Sailaja Ghanta; Kristen Tropea Leeman; Helen Christou
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

Review 2.  Drug therapy for the prevention and treatment of bronchopulmonary dysplasia.

Authors:  Anjali Iyengar; Jonathan M Davis
Journal:  Front Pharmacol       Date:  2015-02-16       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.